S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY

S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY

Bibliographic Details
Main Authors:	Kadère Konté, Liza Afzali-Hashemi, Koen Baas, Anouk Schrantee, Erfan Nur, Aart Nederveen, Bart Biemond
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968028.53603.b7

Similar Items

P1421: THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE
by: Liza Afzali-Hashemi, et al.
Published: (2023-08-01)

P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
by: Kadère Konté, et al.
Published: (2023-08-01)

S278: CEREBRAL HEMODYNAMICS AND OXYGEN METABOLISM IN PATIENTS WITH MILD AND SEVERE SICKLE CELL DISEASE AND THALASSEMIA
by: Liza Afzali-Hashemi, et al.
Published: (2023-08-01)

Impairment of Cerebrovascular Hemodynamics in Patients With Severe and Milder Forms of Sickle Cell Disease
by: Liza Afzali-Hashemi, et al.
Published: (2021-04-01)

Dynamic MR imaging of cerebral perfusion during bicycling exercise
by: Isa H. Mast, et al.
Published: (2022-04-01)

P1465: SAFETY AND EFFICACY OF APOTRANSFERRIN INFUSION IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA, THE AIM STUDY
by: Kadère Konté, et al.
Published: (2023-08-01)

Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease
by: Barriteau CM, et al.
Published: (2022-11-01)

Biophysical chemistry behind sickle cell anemia and the mechanism of voxelotor action
by: Mohd. Suhail
Published: (2024-01-01)

Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
by: Frédéric Galacteros, et al.
Published: (2023-01-01)

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease
by: Paul Telfer, et al.
Published: (2018-05-01)

Quantification of cerebral perfusion and cerebrovascular reserve using Turbo‐QUASAR arterial spin labeling MRI
by: Zhao, M, et al.
Published: (2019)

Cerebral perfusion in cerebral malaria.
by: White, N
Published: (1999)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
by: M Achebe, et al.
Published: (2022-01-01)

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
by: Michael Migotsky, et al.
Published: (2022-09-01)

5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA
by: Y.Q. Qiang, et al.
Published: (2023-04-01)

Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma
by: Radojka M. Savic, et al.
Published: (2022-06-01)

CEREBRAL PERFUSION IN MALARIA
by: Veall, N, et al.
Published: (1984)

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2023-04-01)

P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
by: Biree Andemariam, et al.
Published: (2023-08-01)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
by: Syeda Tayyaba Rehan, et al.
Published: (2022-07-01)

PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY
by: Nirmish Shah, et al.
Published: (2023-08-01)

Cerebral perfusion response to hyperoxia.
by: Bulte, D, et al.
Published: (2007)

Mood and cerebral perfusion revisited.
by: Ebmeier, K
Published: (2000)

The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
by: A Schrantee, et al.
Published: (2017-01-01)

P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2022-06-01)

REAL-WORLD DATA ON THE TREATMENT OF SICKLE CELL DISEASE WITH VOXELOTOR: RESULTS FROM A BRAZIL'S EARLY ACCESS PROGRAM
by: RD Cancado, et al.
Published: (2023-10-01)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
by: Awni Alshurafa, et al.
Published: (2022-09-01)

Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial
by: Satheesh Chonat, et al.
Published: (2024-02-01)

More Unnecessary Imaginary Worlds – Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease
by: Paul Langley
Published: (2020-05-01)

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action
by: Michelle L. Green, et al.
Published: (2022-06-01)

Neurovascular coupling and cerebral perfusion in aging, cerebral microangiopathy and Alzheimer’s diseases
by: Larisa A. Dobrynina
Published: (2018-12-01)

Cerebral perfusion correlates of depressed mood.
by: Ebmeier, K, et al.
Published: (1997)

Gammagrafía de la perfusión cerebral
by: Silvia Vázquez
Published: (2022-06-01)

Cerebral fat embolism in sickle cell disease
by: Hortense Le Bourhis, et al.
Published: (2023-12-01)

P-013: VOXELOTOR REDUCES SICKLE RED BLOOD CELL-MEDIATED HYPOXIC MICROVASCULAR OCCLUSION AS MEASURED BY OCCLUSIONCHIP IN VITRO MICROFLUIDIC ASSAY
by: SEKYONDA Z., et al.
Published: (2022-08-01)

Cerebral hemodynamics in aging: the interplay between blood pressure, cerebral perfusion, and dementia.
by: Ania M. Oleksik, et al.
Published: (2009-04-01)

Central Hemodynamics and Intracranial and Cerebral Perfusion Pressures in Acute Cerebral Circulatory Disorders
by: K. V. Lukashev, et al.
Published: (2009-06-01)

Cerebral blood flow and cerebral saturation in head injury. Comparison of CT perfusion and cerebral near-infrared oxymetry
by: Alexey Trofimov, et al.
Published: (2013-04-01)

Cerebral perfusion in the acute ischemic stroke: clinical and CT-perfusion assessment
by: D. V. Sergeev, et al.
Published: (2017-02-01)

Cerebral perfusion in chronic fatigue syndrome and depression.
by: MacHale, S, et al.
Published: (2000)